<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>NCRI Conference, ASCO Annual Meeting, and Perspectives in Lung Cancer European Congress</title>
  <description>New research for advanced NSCLC showing that combining monoclonal antibodies  and chemotherapy can extend life: OTBN Editor Peter Goodwin and Producer Sarah  Maxwell talk to Robert Pirker, Christian Manegold, Giorgio  Scagliotti, Nick Thatcher, and Howard Sandler, MD. PLUS:  Michel Coleman on the latest findings from the CONCORD study of  international differences in survival rates for breast, prostate, and colorectal  cancers.</description>
  <author_name>OT Broadcast News</author_name>
  <author_url>http://www.oncology-times.com</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/1109847/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/item/1109847</thumbnail_url>
</oembed>
